It was found that the anti-tumour activity of doxorubicin included in the conjugate was significantly higher than that of free doxorubicin, and was attributed to AFP-doxorubicin's specificity for tumour cells and also towards specific features of doxorubicin's entrance and compartmentalization into the cell [29]. Here, AFP is linked to neoplasm.